Overview

A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study is planned to evaluate the safety and efficacy of L059 (levetiracetam) in long-term administration in patients who completed N01020 [NCT00160165] or N01221 [NCT00280696].
Phase:
Phase 3
Details
Lead Sponsor:
UCB Japan Co. Ltd.
Treatments:
Etiracetam
Levetiracetam
Piracetam